Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections–proceedings and data from the Gram-Negative Resistance …

MH Kollef, Y Golan, ST Micek, AF Shorr… - Clinical infectious …, 2011 - academic.oup.com
The emerging problem of antibiotic resistance, especially among Gram-negative bacteria
(GNB), has become a serious threat to global public health. Very few new antibacterial …

Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?

D Koulenti, A Song, A Ellingboe, MH Abdul-Aziz… - International journal of …, 2019 - Elsevier
The spread of multidrug-resistant bacteria is an ever-growing concern, particularly among
Gram-negative bacteria because of their intrinsic resistance and how quickly they acquire …

New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria

AJ O'neill - Expert opinion on investigational drugs, 2008 - Taylor & Francis
Background: Infections caused by multi-drug resistant (MDR) Gram-negative bacteria
represent an ever-growing area of unmet medical need. To address this need, it is …

Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria

LM Avery, DP Nicolau - Expert opinion on investigational drugs, 2018 - Taylor & Francis
Introduction: Infections caused by multidrug-resistant Gram-negative bacteria (MDR-GNB)
are associated with significant mortality and costs. New drugs in development to combat …

10×'20 progress—development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

HW Boucher, GH Talbot, DK Benjamin Jr… - Clinical infectious …, 2013 - academic.oup.com
Infections caused by antibiotic-resistant bacteria, especially the “ESKAPE” pathogens,
continue to increase in frequency and cause significant morbidity and mortality. New …

Developments on antibiotics for multidrug resistant bacterial Gram-negative infections

GL Voulgaris, ML Voulgari… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: The constantly increasing spread of severe infections due to multidrug-resistant
(MDR) Gram-negative bacteria (GNB) is a critical threat to the global medical community …

[HTML][HTML] New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?

H Wright, RA Bonomo, DL Paterson - Clinical Microbiology and Infection, 2017 - Elsevier
Abstract Background Antibiotic resistance in Gram-negative resistance has developed
without a commensurate response in the successful development of antibiotic agents …

[HTML][HTML] Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents

A Provenzani, AR Hospodar, AL Meyer… - International Journal of …, 2020 - Springer
Background The discovery of antibiotics several decades ago was a defining moment in
history. They were used to treat previously incurable diseases and save many lives …

Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria

DR Giacobbe, M Mikulska, C Viscoli - Expert review of clinical …, 2018 - Taylor & Francis
Introduction: The emergence and diffusion of multidrug-resistant Gram-negative bacteria
(MDR-GNB) is an unprecedented threat, with prevalences as high as 10–50% being …

Global antimicrobial resistance in Gram-negative pathogens and clinical need

U Theuretzbacher - Current opinion in microbiology, 2017 - Elsevier
Highlights•Carbapenem-resistant Gram-negative pathogens are a priority for R&D,
according to WHO.•Increasing need for new therapies against Klebsiella, Pseudomonas and …